|
|
Blood, 1 June 2008, Vol. 111, No. 11, pp. 5400-5402.
Prepublished online as a Blood First Edition Paper on March 31, 2008; DOI 10.1182/blood-2008-02-137703.
Previous Article | Next Article 
Submitted February 5, 2008
Accepted March 19, 2008
Novel Exon 12 mutations in the HIF2A gene associated with erythrocytosis
Melanie J Percy*, Philip A Beer, Gavin Campbell, Ad W Dekker, Anthony R Green, David Oscier, Glenn Rainey, Richard van Wijk, Marion Wood, Terence RJ Lappin, Mary Frances McMullin, and Frank S Lee
Department of Haematology, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
Department of Haematology, University of Cambridge, Cambridge, United Kingdom
Essex Rivers Healthcare NHS Trust, Colchester General Hospital, Colchester, Essex, United Kingdom
Department of Clinical Hematology, University Medical Center Utrecht, Utrecht, Netherlands
Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom
Department of Haematology, Vale of Leven District General Hospital, Alexandria, Dunbartonshire, United Kingdom
Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, Netherlands
Centre for Cancer Research and Cell Biology, Queen's University, Belfast, Northern Ireland, United Kingdom
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, United States
* Corresponding author; email: melanie.percy{at}belfasttrust.hscni.net.
Erythrocytosis can arise from deregulation of the erythropoietin (Epo) axis due to defects in the oxygen-sensing pathway. Epo synthesis is controlled by the Hypoxia Inducible Factor (HIF) complex, composed of an and a subunit. There are two main a subunits, HIF-1 and HIF-2 . Recently, a HIF-2 Gly537Trp mutation was identified in a family with erythrocytosis. This raises the possibility of HIF2A mutations being associated with other cases of erythrocytosis. We now report a subsequent analysis of HIF2A in a cohort of 75 erythrocytosis patients, and identify four additional patients with novel heterozygous Met535Val and Gly537Arg mutations. All individuals presented at a young age with elevated serum Epo. Mutations at Gly-537 account for four of five HIF2A mutations associated with erythrocytosis. These findings support the importance of HIF-2 in human Epo regulation and warrant investigation of HIF2A in patients with unexplained erythrocytosis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. L. Semenza
Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis
Blood,
September 3, 2009;
114(10):
2015 - 2019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Furlow, M. J. Percy, S. Sutherland, C. Bierl, M. F. McMullin, S. R. Master, T. R. J. Lappin, and F. S. Lee
Erythrocytosis-associated HIF-2{alpha} Mutations Demonstrate a Critical Role for Residues C-terminal to the Hydroxylacceptor Proline
J. Biol. Chem.,
April 3, 2009;
284(14):
9050 - 9058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Percy and F. S. Lee
Familial erythrocytosis: molecular links to red blood cell control
Haematologica,
July 1, 2008;
93(7):
963 - 967.
[Full Text]
[PDF]
|
 |
|
|
|